Literature DB >> 1544230

Effect of 12,13-phorbol dibutyrate and ionomycin on defective B cells in common variable immunodeficiency.

A Franz1, A Bryant, A D Webster, J Farrant.   

Abstract

Secretion of IgM and IgG in vitro by B cells from patients with common variable immunodeficiency (CVI) has been used to classify the disease into three groups. On stimulation with anti-IgM and IL-2, group A patients' cells fail to secrete IgM or IgG, group B patients' cells secrete no IgG and significantly lower levels of IgM than normal cells, and group C patients' cells produce normal levels of both isotypes. Direct activation of protein kinase C using 12,13-phorbol dibutyrate and ionomycin followed by IL-2 or IL-4 has been reported to induce immunoglobulin secretion by normal human B cells. We therefore attempted to induce B cells from group A and group B CVI patients to secrete IgM and IgG after direct activation of protein kinase C together with IL-2 or IL-4. The data show that the failure of secretion of immunoglobulin by B cells from CVI patients could not be reversed using this approach. This finding suggests that the activation channel involving protein kinase C in B cells from CVI patients is not involved in the defect in cell differentiation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1544230      PMCID: PMC1554328          DOI: 10.1111/j.1365-2249.1992.tb03020.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  14 in total

Review 1.  Cellular abnormalities in common variable immunodeficiency.

Authors:  G P Spickett; A D Webster; J Farrant
Journal:  Immunodefic Rev       Date:  1990

2.  Primary immunodeficiency diseases. Report of a WHO sponsored meeting.

Authors: 
Journal:  Immunodefic Rev       Date:  1989

3.  B cell function in acquired "common-variable" hypogammaglobulinemia: proliferative responses to lymphokines.

Authors:  J Farrant; A Bryant; F Almandoz; G Spickett; S W Evans; A D Webster
Journal:  Clin Immunol Immunopathol       Date:  1989-05

4.  Role of interleukin-2 and interleukin-6 in the mitogen responsiveness of T cells from patients with 'common-variable' hypogammaglobulinaemia.

Authors:  M E North; A D Webster; J Farrant
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

5.  Conditions for measuring DNA synthesis in PHA stimulated human lymphocytes in 20 microliters hanging drops with various cell concentrations and periods of culture.

Authors:  J Farrant; J C Clark; H Lee; S C Knight; J O'Brien
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

6.  Role of veiled cells in lymphocyte activation.

Authors:  S C Knight; B M Balfour; J O'Brien; L Buttifant; T Sumerska; J Clarke
Journal:  Eur J Immunol       Date:  1982-12       Impact factor: 5.532

7.  Defective DNA synthesis by T cells in acquired 'common-variable' hypogammaglobulinaemia on stimulation with mitogens.

Authors:  M E North; G P Spickett; J Allsop; A D Webster; J Farrant
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

8.  Immunoglobulin isotype production by cycling human B lymphocytes in response to recombinant cytokines and anti-IgM.

Authors:  L Flores-Romo; M J Millsum; S Gillis; P Stubbs; C Sykes; J Gordon
Journal:  Immunology       Date:  1990-03       Impact factor: 7.397

9.  Classification of patients with common variable immunodeficiency by B cell secretion of IgM and IgG in response to anti-IgM and interleukin-2.

Authors:  A Bryant; N C Calver; E Toubi; A D Webster; J Farrant
Journal:  Clin Immunol Immunopathol       Date:  1990-08

10.  Defective low-density cells of dendritic morphology from the blood of patients with common variable hypogammaglobulinaemia: low immunoglobulin production on stimulation of normal B cells.

Authors:  J Farrant; A E Bryant; A M Lever; A J Edwards; S C Knight; A D Webster
Journal:  Clin Exp Immunol       Date:  1985-07       Impact factor: 4.330

View more
  2 in total

1.  Activated B cells from patients with common variable immunodeficiency proliferate and synthesize immunoglobulin.

Authors:  S Nonoyama; M Farrington; H Ishida; M Howard; H D Ochs
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

Review 2.  Common variable immunodeficiency.

Authors:  W Strober; K Chua
Journal:  Clin Rev Allergy Immunol       Date:  2000-10       Impact factor: 10.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.